Papers In Press, published online ahead of print August 8, 2006
J. Biol. Chem, 10.1074/jbc.M513471200
Submitted on December 19, 2005
Revised on August 7, 2006
Accepted on August 8, 2006
PLC
suppresses integrin activation
Yatish Lad, Brian McHugh, Philip S. Hodkinson, Alison MacKinnon, Christopher Haslett, Mark H. Ginsberg, and Tariq Sethi
Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4SA
Corresponding Author: pshodkinson{at}hotmail.com
PLC
is a newly described effector of the small GTP-binding protein H-Ras. Utilizing H-Ras effector mutants, we show that the mutants H-Ras(G12V/E37G) and H-Ras(G12V/D38N) suppress integrin activation in an ERK-independent manner. H-Ras(G12V/D38N) specifically activates the PLC
effector pathway and suppresses integrin activation. Inhibition of PLC
activation with a kinase dead PLC
mutant prevented H-Ras(G12V/D38N) from suppressing integrin activation and low-level expression of H-Ras(G12V/D38N) can synergize with wild type PLC
to suppress integrins. In addition knockdown of endogenous PLC
with siRNA blocked H-Ras(G12V/D38N) mediated integrin suppression. Importantly, suppressing integrin function with the H-Ras (G12V/D38N) mutant reduced cell adhesion to von-Willebrand Factor and fibronectin - this reduction in cell adhesion was blocked by co-expression of the kinase dead PLC
mutant. These results show that H-Ras suppresses integrin affinity via independent Raf and PLC
signaling pathways, and demonstrate a new physiological function for PLC
in the regulation of integrin activation.